View in EDS HTML Full Text PDF Full Text

The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.

Saved in:
Bibliographic Details
Title: The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
Authors: Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Mascia M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Barreca M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Licenziato L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Veterinary Sciences, University of Turin, Turin, Italy., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Ferragamo A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Pileri S; Division of Diagnostic Haematopathology, European Institute of Oncology, Milan, Italy., Damia G; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Politz O; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany., Wengner AM; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Source: British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 191-205. Date of Electronic Publication: 2023 Nov 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38011941
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sartori+G%22">Sartori G</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tarantelli+C%22">Tarantelli C</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Spriano+F%22">Spriano F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gaudio+E%22">Gaudio E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cascione+L%22">Cascione L</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mascia+M%22">Mascia M</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Barreca+M%22">Barreca M</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Arribas+AJ%22">Arribas AJ</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Licenziato+L%22">Licenziato L</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Veterinary Sciences, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Golino+G%22">Golino G</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferragamo+A%22">Ferragamo A</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pileri+S%22">Pileri S</searchLink>; Division of Diagnostic Haematopathology, European Institute of Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Damia+G%22">Damia G</searchLink>; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zucca+E%22">Zucca E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stathis+A%22">Stathis A</searchLink>; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Politz+O%22">Politz O</searchLink>; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Wengner+AM%22">Wengner AM</searchLink>; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bertoni+F%22">Bertoni F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 191-205. <i>Date of Electronic Publication: </i>2023 Nov 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38011941
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.19218
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 191
    Titles:
      – TitleFull: The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sartori G
      – PersonEntity:
          Name:
            NameFull: Tarantelli C
      – PersonEntity:
          Name:
            NameFull: Spriano F
      – PersonEntity:
          Name:
            NameFull: Gaudio E
      – PersonEntity:
          Name:
            NameFull: Cascione L
      – PersonEntity:
          Name:
            NameFull: Mascia M
      – PersonEntity:
          Name:
            NameFull: Barreca M
      – PersonEntity:
          Name:
            NameFull: Arribas AJ
      – PersonEntity:
          Name:
            NameFull: Licenziato L
      – PersonEntity:
          Name:
            NameFull: Golino G
      – PersonEntity:
          Name:
            NameFull: Ferragamo A
      – PersonEntity:
          Name:
            NameFull: Pileri S
      – PersonEntity:
          Name:
            NameFull: Damia G
      – PersonEntity:
          Name:
            NameFull: Zucca E
      – PersonEntity:
          Name:
            NameFull: Stathis A
      – PersonEntity:
          Name:
            NameFull: Politz O
      – PersonEntity:
          Name:
            NameFull: Wengner AM
      – PersonEntity:
          Name:
            NameFull: Bertoni F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 204
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1